MyAmyloidosisTeam

Diflunisal and tafamidis are both used to treat amyloidosis, but they have different approval statuses and mechanisms:

- Diflunisal: Not officially approved to treat amyloidosis but used off-label. It may improve survival rates and help manage symptoms
- Tafamidis: FDA-approved for treating hATTR amyloidosis. Studies show Show Full Answer

Diflunisal and tafamidis are both used to treat amyloidosis, but they have different approval statuses and mechanisms:

- Diflunisal: Not officially approved to treat amyloidosis but used off-label. It may improve survival rates and help manage symptoms.
- Tafamidis: FDA-approved for treating hATTR amyloidosis. Studies show it improves neurological function, delays disease progression, and enhances quality of life.

While both can be beneficial, tafamidis has more robust evidence supporting its efficacy and safety. Always consult your doctor for personalized advice.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

hATTR Amyloidosis Treatments: Comparing Your Options | MyAmyloidosisTeam

Treatments for Amyloidosis | MyAmyloidosisTeam